Transmutex develops accelerator-powered technology that transforms existing nuclear waste into clean energy while producing radioisotopes for medical applications. This process reduces the volume and radiotoxicity of long-lived nuclear waste, enabling safe decay in under 500 years and addressing the challenges of nuclear waste management.
Funding
$21.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
USFounders
Product
Problem
Existing nuclear reactors generate long-lived radioactive waste that requires deep geological storage for hundreds of thousands of years, posing environmental and safety challenges. Concerns about meltdown accidents and the proliferation of military-grade material further complicate the expansion of nuclear energy.
Solution
Transmutex is developing an accelerator-driven subcritical reactor technology that transmutes existing nuclear waste into clean energy and medical radioisotopes. By using a particle accelerator to initiate and control the nuclear reaction, the system eliminates the risk of meltdown accidents and reduces the volume and radiotoxicity of long-lived waste. The transmutation process converts problematic waste into shorter-lived isotopes, decreasing the required storage time to under 500 years and minimizing proliferation risks. This approach offers a safer, more sustainable alternative to traditional nuclear fission, addressing waste management challenges while providing carbon-free energy and valuable medical resources.
Target Audience
The primary target audience includes nuclear power plant operators, energy companies, healthcare providers, and government agencies seeking advanced solutions for nuclear waste management, clean energy production, and medical isotope supply.
Features
- Accelerator-driven subcritical reactor design ensures inherent safety and prevents meltdown accidents.
- Transmutation process reduces the volume and radiotoxicity of long-lived nuclear waste.
- Production of radioisotopes for medical diagnostics and treatment.
- Potential to utilize thorium as fuel, offering a more abundant and proliferation-resistant resource.
- Liquid lead cooling technology enables walk-away safe operation with self-cooling properties.
- System can be shut down within 2 milliseconds via the particle accelerator.